coteauBeta Get App
FMS

FMS

Fresenius Medical Care AG
$21.62
+0.98% Oct 21 close
Healthcare Compare
-25%-15%-4%+7%+17%Oct 2025Oct 2026Apr 2026
FMSSPY
1W
+0.4%
1M
-2.7%
3M
-11.0%
6M
-1.6%
YTD
-5.6%
1Y
-17.1%

Live chart

Loading live chart…

What they do

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics.

Healthcare · Medical Care Facilities

For information only · Important disclosures

Grades vs sector

No sector grades for FMS yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
PR Newswire · Oct 19
Robinson Unmanned to Deliver Blue UAS Cleared Spirit UAS to Nepali Army Under Ascent Aerosystems FMS Contract
GlobeNewswire · Oct 13
Truist Trims Price Target on Fresenius Medical Care to $24 From $25, Keeps Hold Rating
MT Newswires · Oct 12
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Zacks · Oct 07
Fresenius Medical Care Names Shervin Korangy as CEO, Board Chair
MT Newswires · Oct 07

Key stats

Market value$11.5B
P/E (last 12 months)11.1
P/E (next 12 months, estimated)7.3
52-week range$20.02 – $27.43
Revenue growth (latest quarter vs a year ago)+1.4%
Dividend yield4.07%
Analyst consensusHold (7)
Average analyst price target$23.90 (+11%)
Valuation and fundamentals

Valuation & fundamentals

No US-GAAP 10-K/10-Q financials in SEC data (foreign filers report on Form 20-F, often under IFRS).

Earnings

Next report: 2026-11-03 · during market · EPS est 0.53
24-1125-0225-0525-0825-1126-0226-0526-080.000.72
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-030.500.56+13.1%
2026-05-030.500.46-8.6%
2026-02-240.550.72+30.0%
2025-11-040.500.55+9.1%
2025-08-050.470.46-2.4%
2025-05-060.380.42+9.7%
2025-02-240.400.46+13.6%
2024-11-050.350.41+16.0%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$4.9B+1.4%
2026-03-31$4.6B–
2025-12-31$5.1B–
2025-09-30$4.9B–
2025-06-30$4.8B–
Analyst actions
Truist Securities
2026-10-12 · main
Hold → Hold
PT $24
Bernstein
2026-08-06 · main
Market Perform → Market Perform
PT $26
UBS
2025-09-02 · down
Neutral → Sell
Truist Securities
2025-05-12 · main
Hold → Hold
PT $30
Truist Securities
2025-01-06 · main
Hold → Hold
PT $25
Truist Securities
2024-10-07 · main
Hold → Hold
PT $23

Recent dividends

2026-05-22: $0.872 · 2025-05-23: $0.815 · 2024-05-17: $0.634 · 2023-05-17: $0.618 · 2022-05-13: $0.709 · 2021-05-24: $0.834 · 2020-08-28: $0.707 · 2019-05-17: $0.655

Stats refreshed 2026-10-21 12:15:15 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026